OM Pharma SA
OM Pharma SA is a Biotech company based in Meyrin (Geneva) recorded by Swissmedic as the authorisation holder for 12 human medicines. That places it 129 of 334 authorisation holders in Switzerland. Its portfolio is concentrated in Synthetika.
Key facts
| Sector | Biotech |
|---|---|
| City | Meyrin |
| Canton | Geneva |
| Authorisation holder | Yes |
| Medicines | 12 |
| Founded | 1936 |
| Employees | 201-1000 |
| Parent group | Not available |
| Activity | Not available |
| Website | ompharma.com |
Medicines authorised in Switzerland
OM Pharma SA is recorded by Swissmedic as the authorisation holder for 12 human medicines. The table shows 12 of them with product code and dispensing category.
Portfolio by product code
Portfolio by dispensing category
12 of 12 authorisations
| Name | Authorisation number | Dispensing category | ATC | First authorised |
|---|---|---|---|---|
| Broncho-Vaxom | 59399 | D | - | 2009-08-12 |
| Broncho-Vaxom adultes | 596 | D | R07AX | 1997-07-03 |
| Broncho-Vaxom enfants | 597 | D | R07AX | 1997-07-03 |
| Broncho-Vaxom enfants | 667 | D | R07AX | 2003-04-10 |
| Dicynone 250 | 27048 | B | B02BX01 | 1962-05-22 |
| Dicynone 500 | 27047 | B | - | 1962-05-22 |
| Dicynone 500 | 57577 | B | B02BX01 | 2008-05-09 |
| Doxiproct | 38932 | D | C05AD01 | 1975-04-02 |
| Doxiproct Plus | 38934 | B | C05AA09 | 1975-04-22 |
| Doxium 1000 mg | 61059 | B | C05BX01 | 2011-04-20 |
| Doxium 500 | 39217 | B | C05BX01 | 1975-12-15 |
| Uro-Vaxom | 598 | B | G04BX | 1998-03-19 |
Frequently asked questions
How many medicines does OM Pharma SA have authorised in Switzerland?
OM Pharma SA is recorded by Swissmedic as the authorisation holder for 12 human medicines (as of 1 September 2026). Different strengths under one authorisation number are not counted separately.
Where is OM Pharma SA based?
The Swiss location recorded for OM Pharma SA is Meyrin, Geneva.
Is OM Pharma SA a Swissmedic authorisation holder?
Yes. OM Pharma SA appears in the official Swissmedic list of authorised medicinal products as an authorisation holder. Under the Therapeutic Products Act (TPA) the holder is responsible for the quality, safety and product information of its medicines in Switzerland.